Freshly Printed - allow 7 days lead
Couldn't load pickup availability
Iatrogenicity
Causes and Consequences of Iatrogenesis in Cardiovascular Medicine
Ihor B. Gussak (Edited by), John B. Kostis (Edited by), Ibrahim Akin (Edited by), Martin Borggrefe (Edited by), Giovanni Campanile (Edited by), Arshad Jahangir (Edited by), William J Kostis (Edited by), Gan-Xin Yan (Edited by), Fatima Ali (Contributions by), Uzair Ansari (Contributions by), Gloria Bachmann (Contributions by), George L Bakris (Contributions by), Joseph A Barone (Contributions by), Stefan Baumann (Contributions by), Tobias Becher (Contributions by), Michael Behnes (Contributions by), Edo Y Birati (Contributions by), Chrysoula Boutari (Contributions by), Giovanni Campanile (Contributions by), Haiming Cao (Contributions by), Kyriakos Dimitriadis (Contributions by), Jeanne M Dobrzynski (Contributions by), Christina Dosch (Contributions by), Michael Doumas (Contributions by), Camilo Fernandez (Contributions by), Christie Fleetwood (Contributions by), Aatish Garg (Contributions by), Thomas D Giles (Contributions by), Miriam A Gonzalez-Siegel (Contributions by), Guido Grassi (Contributions by), Georg Gussak (Contributions by), Maria L Gussak (Contributions by), Yuya Hagiwiara (Contributions by), Evelyn R Hermes-DeSantis (Contributions by), Konstantinos Imprialos (Contributions by), Vibha Iyengar (Contributions by), Ahad Jahangir (Contributions by), Mariell Jessup (Contributions by), Stephen K Jones (Contributions by), Rigas G Kalaitzidis (Contributions by), Ariba Khan (Contributions by), Dimitris Kostantinidis (Contributions by), William J Kostis (Contributions by), Rajesh Kumar (Contributions by), Jurgen Kushyck (Contributions by), Pauline O Lerma (Contributions by), Volker Liebe (Contributions by), Dirk Loznitzer (Contributions by), Thomas Makris (Contributions by), Michael Malone (Contributions by), Giuseppe Mancia (Contributions by), Jawahar L. Mehta (Contributions by), Abel E Moreyra (Contributions by), Aalap Narichania (Contributions by), Michael S Nolledo (Contributions by), Vasilios Papademetriou (Contributions by), Theano Papavassiliu (Contributions by), Neela Patel (Contributions by), Hakan Paydak (Contributions by), VJ Periyakoil (Contributions by), Nancy Phillips (Contributions by), Naga Venkata Pothineni (Contributions by), Margaret Rees (Contributions by), Susanne Roger (Contributions by), Boris Rudic (Contributions by), Gary E Sander (Contributions by), Teodoro V Santiago (Contributions by), Gino Seravalle (Contributions by), Win K Shen (Contributions by), Konstantinos Stavropoulos (Contributions by), Sulaiman Sultan (Contributions by), A Jamil Tajik (Contributions by), Costas Thomopoulos (Contributions by), Dimitris Tousoulis (Contributions by), Kostantinos P Tsioufis (Contributions by), Erol Tulumen (Contributions by), Nikolaos Vogiatzakis (Contributions by), Thomas J Watson (Contributions by), Yasuhiro Yokoyama (Contributions by)
9780813586410
Hardback, published 15 December 2017
448 pages, 32 line drawings
25.4 x 17.8 x 3 cm, 1.021 kg
Edited by two renowned cardiology experts, Iatrogenicity: Causes and Consequences of Iatrogenesis in Cardiovascular Medicine addresses both the iatrogenicity that arises with cardiovascular interventions, as well as non-cardiovascular interventions that result in adverse consequences on the cardiovascular system. The book aims to achieve three things: to summarize the available information on this topic in a single high-yield volume; to highlight the human and financial cost of iatrogenesis; and to describe and propose potential interventions to ameliorate the effects of iatrogenesis. This accessible book is a practical reference for any practicing physician who sees patients with cardiovascular issues. .
TABLE OF CONTENTS Part I: MEDICAL HARM 1. The Concept and Spectrum of "Iatrogenicity" I. Gussak and J. Kostis 2. Iatrogenicity: Definition, History and Modern Context M. Gussak, I. Gussak, and J. Kostis 3. Epidemiology and Public Health Aspects and Implications: Regulatory, Legal and Ethical Dimensions of Iatrogenicity S. Jones and M. Gonzalez 4. Risk Management: The Medical Center Administration Perspective S. Jones and M. Gonzalez 5. Iatrogenicity from the Patient's Perspective J. Dobrzynski, S. Jones, and M. Gonzalez 6. A Naturopathic Perspective on Iatrogenesis C. Fleetwood Part II: IATROGENICITY OF CARDIOVASCULAR DURGS AND CARDIOVASCULAR TOXICITY OF NON-CARDIAC DRUGS 7. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and Syndromes I. Gussak, G. Yan, A. Jahangir, and J. Kostis 8. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death A. Narichania, Y. Yokoyama, and W.K. Shen 9. Chemotherapy-Induced Cardiomyopathies E. Birati and B. Jessup 10. Iatrogenicity of Blood Pressure Mesaurement in the Diagnosis of Hypertension T. Giles, G. Sander, I. Gussak, and J. Kostis 11. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes R. Kalaitzidis and G. Bakris 12. Iatrogenicity of Cardiovascular Drugs Associated with Cardiac and Non-Cardiac Toxicities: Antihypertensive Agents and Biologics E. Hermes-Desantis and J. Barone 13. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia C. Thomopoulos and T. Makris 14. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect G. Bachmann, M. Rees, and N. Phillips 15. Iatrogenic Aspects of Lipid-Lowering Agents, Thrombolytic, Antiplatelet, and Antithrombotic Agents C. Tsioufis, D. Konstantinidis, N. Vogiatzakis, and K. Dimitriadis 16. Iatrogenic Effects of ‘Urologic' Drugs on the Cardiovascular System K. Stavropoulos, C. Boutari, K. Imprialos, and M. Doumas 17. Iatrogencity and Antianginal Drugs A. Moreyra and W.J. Kostis 18. Anti-Diabetic Drugs and Cardiovascular Risk: Where Do We Stand? R. Kumar 19. Cardiovascular Iatrogenicity in Older Adults A. Khan, #. Ali, #. Iyengar, #. Hagiwara, #. Periyakoil, #. Patel, #. Malone Part III: IATROGENCITY OF DIAGNOSTIC AND THERAPEUTIC, INVASIVE AND NON-INVASIVE CARDIOVASCULAR INTERVENTION, DEVICES, AND SURGERIES 20. Iatrogenic Aspects of Non-Invasive and Invasive Diagnostic Methods in Interventional Cardiology C. DÖsch, D. Loßnitzer, T. Papavassiliu 21. Iatrogenicity Associated with Interventional Treatment Modalities N.V. Pothineni, A. Garg, H. Paydak, and J.L. Mehta 22. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Non-Invasive Cardiovascular Interventions, Devices and Surgeries M. Behnes, T. Becher, S. Baumann, and I. Akin 23. Iatrogenic Aspects in Cardiac Electrophysiology B. Rudic, E. TÜlÜmen, and V. Liebe 24. Iatrogenic Aspects in Cardiac Device Therapy S. RÖger and J. Kuschyk 25. Cardiovascular Iatrogencity of Respiratory Therapeutic Modalities M.S. Nolledo, P. Lerma and T.V. Santiago Part IV: IATROGENIC ASPECTS OF SPORT CARDIOLOGY AND LIFE-STYLE MODIFICATIONS 26. Professional Athletes G. Mancia 27. Sports Cardiology G. Campanile 28. Dangers of Lifestyle Modification Advice G. Campanile Part V: IATROGENICITY OF DIETARY SUPPLEMENTS, HERBAL PRODUCTS, AND OTHER NON-TRADITIONAL THERAPIES IN CARDIOVASCULAR MEDICINE 29. Safety of Over-the-Counter ‘Natural Substances’ and Vitamins: Side-effects and Contraindications S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir 30. Interactions Between Supplements and Prescription Medications S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir Acknowledgments Index